Resolution In Support Of The De-Scheduling Of Cannabis

Share This

Facebooktwitter

Cannabis is a natural non-toxic plant that is biologically synergistic with human health and wellness:

Whereas, Cannabis has been used as a food source and an herbal medicine for thousands of years throughout the world; and,

Whereas, Cannabis in its natural form has a remarkably wide margin of safety and there have been no recorded overdose deaths by cannabis throughout centuries of human use; and,

Whereas, Cannabis in its fresh and natural form is not psychoactive, but rather a nutritious food source; and,

Whereas, Cannabis has a low risk of addiction with minor withdrawal symptomology and, in fact, can be utilized in opioid harm reduction; and,

Whereas, Cannabis was inappropriately omitted from the U.S. Pharmacopoeia in 1941 based on the reefer madness campaign that led to the passage of the Marihuana Tax Act of 1937 (Bonnie and Whitebread, 1974) that demonized the plant as a dangerous new drug; and,

Whereas, the United States Government had incorrectly and arbitrarily placed cannabis into Schedule 1 (forbidden category) of the controlled substances under the Controlled Substances Act of 1970 based on old myths and political ideology; and,

Whereas, in 1972 the “Shafer Commission” (The National Commission on Marihuana and Drug Abuse) found that marihuana (cannabis) did not meet the criteria for Schedule I placement; and,

Whereas, in a petition to Drug Enforcement Administration (DEA) to remove cannabis from Schedule I, the DEA’s own Administrative Law Judge, Francis Young ruled that cannabis did not belong in Schedule I, but the Director of the DEA rejected Judge Young’s ruling1 (Washington, DC U.S. Department of Justice, 1988); and,

Whereas, the primary psychoactive substance in Cannabis is THC and the pharmaceutical product, dronabinol (synthetic THC in Sesame oil) was down-regulated from Schedule 2 to Schedule 3 of the controlled substances due to its safety and lack of diversion, and per the DEA’s own rules, a plant should not be more restricted than its primary psychoactive constituent; and,

Whereas, the American Herbal Pharmacopoeia published a monograph, Cannabis Inflorescence, which provides quality and safety standards for this herbal plant (AHP, 2013); and

Whereas, the public has been allowed to grow and use herbal plants without a prescription; and,

Whereas, 8 states (AK, CA, CO, MA, ME, NV, OR, and WA) and Washington, DC allow use of cannabis by adults, causing much confusion between state and federal laws; and,

Whereas, the prohibition of cannabis has resulted in cruel punishment to countless individuals for simply growing the plant or possessing its harvested flowers; and,

Whereas, the prohibition of this plant has diverted our law enforcement and their resources away from violent criminals and true criminal activities; and,

Whereas, due to the cannabis prohibition numerous non-violent individuals have been imprisoned, resulting not only in destroying their lives, but adding pain and suffering to their loved ones in their absence; and,

Whereas, the cannabis plant is highly beneficial to our environment when allowed to grow naturally (Clark & Pate, 1997); and

Whereas, cannabis may be an essential nutrient for those suffering from health problems caused by an endocannabinoid deficiency (Russo, 2016); and,

Whereas, this resolution is not addressing pharmaceutical alterations of concentrates, or extractions of specific cannabinoids, or the synthesis of any of the active constituents of cannabis;

Therefore be it resolved that PATIENTS OUT OF TIME will:

1. Promote the nutritional and healing value of this herbal plant.
2. Educate its members and the public about the safe cultivation, storage, and use of herbal cannabis.
3. Support the end of the cannabis prohibition.
4. Encourage its members to use this resolution to petition their state legislators and the federal government to end the cannabis prohibition.
5. Urge the DEA to de-schedule Cannabis and end the prohibition on this highly beneficial plant.
6. Support pesticide- and herbicide-free cultivation of this plant by commercial growers.
7. Support the immediate release of those convicted of marijuana growing, possessing, or consuming charges.

References:

American Herbal Pharmacopoeia. (2013). Cannabis Inflorsence. ScottsValley, CA: American Herbal Pharmacopoeia.
Bonnie RJ & Whitebread, II, CH (1974). The Marihuana Conviction: A History of the Marihuana Prohibition in the United States. Charlottesville: University Press of Virginia.
Clarke RC & Pate DW. (1997). Economic and environmental potential of cannabis (pp. 192-211), in Cannabis in Medical Practice; A Legal, Historical and Pharmacological Overview of the Therapeutic Use of Marijuana, edited by ML Mathre. Jefferson, NC: McFarland & Company, Inc.
National Commission on Marihuana and Drug Abuse. (1972). Marihuana: A Signal of Misunderstanding. Washington, DC: National Academy Press.
Russo EB. (2016). Clinical endocannabinoid deficiency Reconsidered: Current research supports the theory in migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes. Cannabis and Cannabinoid Research. 1(1):154-165. DOI:10.1089/can.2016.0009.
Washington, DC, U.S. Department of Justice, Drug Enforcement Administration. (September 6, 1988). In the matter of marijuana rescheduling petition, Dkt. No. 86-22, opinion, recommended ruling, findings of fact, conclusion of law, and decision of administrative law judge.

Approved:

In December 2016, Patients Out of Time submitted a petition to the White House urging immediate de-scheduling.

Follow Us

Facebooktwitteryoutube

Share This

Facebooktwitter

Grow Training with Jorge Cervantes

  • Two US House Republicans pitch federal marijuana legalization bill
    by Jeff Smith on May 13, 2021 at 4:57 pm

    Two Republican congressmen in the U.S. House of Representatives have introduced a bill that would legalize marijuana federally in a manner similar to alcohol. The bill, “Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act,” is sponsored by Reps. David Joyce of Ohio and Don Young of Alaska. The two congressmen are Two US House Republicans pitch federal marijuana legalization bill is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

  • Cannabis firms ready FDA ingredient notifications with eye on legalization
    by Kristen Nichols on May 13, 2021 at 10:30 am

    Cannabis manufacturers with national ambitions for when the United States legalizes marijuana and CBD are plowing big money into telling the federal government exactly what they’re making - and being honest when their products elicit consumer complaints. Cannabis firms ready FDA ingredient notifications with eye on legalization is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

  • Financial-violation allegations cost Maui cannabis dispensary its license
    by John Schroyer on May 12, 2021 at 10:33 pm

    Hawaii regulators ordered a medical cannabis dispensary on the island of Maui to close immediately because of the company’s “ongoing failure to submit annual independent financial audits.” According to Hawaii News Now, the dispensary, Pono Life Sciences Maui, was ordered to cease operations without further delay via a Department of Health Notice of Violation and Financial-violation allegations cost Maui cannabis dispensary its license is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

  • Colorado’s first-quarter retail marijuana sales up 28% from 2020
    by Omar Sacirbey on May 12, 2021 at 9:05 pm

    Recreational and medical marijuana retailers in Colorado continue to break sales records. According to the latest data from the state Department of Revenue, Colorado’s adult-use and medical cannabis stores recorded $561.7 million in sales in the first quarter of 2021. That’s a 28% increase over the $438.8 million the state’s cannabis retailers racked up in 2020. Colorado’s first-quarter retail marijuana sales up 28% from 2020 is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

  • MA cannabis businesses forced to pay $2.5M in unlawful fees, study shows
    by Jeff Smith on May 12, 2021 at 5:52 pm

    Cannabis companies in Massachusetts have paid at least $2.46 million in fees more than lawfully allowed under “host community agreements” (HCAs), according to a new study that reiterates the need for reform. The study, paid for by the Massachusetts Cannabis Business Association and conducted by the University of Massachusetts in Boston, was released Tuesday during MA cannabis businesses forced to pay $2.5M in unlawful fees, study shows is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

  • How to ensure adequate water supply for outdoor cannabis in a drought
    by Kristen Nichols on May 12, 2021 at 10:30 am

    Water is a must for successfully producing hemp and marijuana, so making sure to have enough for the growing season and tapping into an irrigation system are critical tasks for cannabis cultivators. How to ensure adequate water supply for outdoor cannabis in a drought is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Translate »

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!